ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 17 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $39,863,000 | +33.3% | 22,070,000 | 0.0% | 0.03% | +24.0% |
| Q2 2017 | $29,896,000 | +15.1% | 22,070,000 | +20.6% | 0.02% | +4.2% |
| Q1 2017 | $25,982,000 | +1.1% | 18,306,000 | 0.0% | 0.02% | -7.7% |
| Q4 2016 | $25,712,000 | +109.2% | 18,306,000 | +77.6% | 0.03% | +116.7% |
| Q3 2016 | $12,292,000 | +27.2% | 10,306,000 | -8.8% | 0.01% | +9.1% |
| Q2 2016 | $9,667,000 | +17.4% | 11,302,000 | +9.7% | 0.01% | +10.0% |
| Q1 2016 | $8,233,000 | +96.5% | 10,302,000 | +128.9% | 0.01% | +100.0% |
| Q4 2015 | $4,190,000 | -5.0% | 4,500,000 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $4,412,000 | -36.8% | 4,500,000 | -18.2% | 0.00% | -33.3% |
| Q2 2015 | $6,982,000 | -20.7% | 5,500,000 | -21.4% | 0.01% | -25.0% |
| Q1 2015 | $8,805,000 | +192.3% | 7,000,000 | +141.4% | 0.01% | +100.0% |
| Q1 2014 | $3,012,000 | -84.5% | 2,900,000 | -84.3% | 0.00% | -84.0% |
| Q4 2013 | $19,384,000 | -9.6% | 18,500,000 | 0.0% | 0.02% | -24.2% |
| Q3 2013 | $21,437,000 | +125.8% | 18,500,000 | +85.0% | 0.03% | +106.2% |
| Q2 2013 | $9,495,000 | – | 10,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|